Skip Navigation Skip to main content
  • Warning Signs
  • Volunteer
  • Donate
return to American Heart Association Newsroom
  • Heart Attack And Stroke Symptoms
  • Volunteer
  • Donate
Newsroom
    • News Media Embargoed Access
    • Login to Password Protected Newsroom
    • Apply for Embargoed Access
    • Embargo Policy and Guidelines
    • American Heart Association Fact Sheets
    • Boilerplates
    • Copyright Permissions
    • Glossary of Scientific Terms
    • Linking Policy
    • Scientific Statements/Guidelines
    • Scientific Publications: Purposes-Processes
    • Statistics
    • Multimedia Resources
    • Animation/Video
    • Images/Graphics
    • Audio
    • Usage Policy
    • Connect With Us
    • Media Contacts
    • Consumer/Media Connections
  • Twitter
  • Facebook
  • YouTube
  • RSS
  • Email Alerts
  1. Newsroom
  2. Search News Releases
  3. Precaución recomendada para el tratamiento del COVID-19 con hidroxicloroquina y azitromicina para pacientes con enfermedad cardiovascular
Categories: COVID-19, Foreign Language News Releases
|
Published: April 08, 2020

Precaución recomendada para el tratamiento del COVID-19 con hidroxicloroquina y azitromicina para pacientes con enfermedad cardiovascular

Guía de la American Heart Association, el American College for Cardiology y la Hearth Rhythm Society
facebook Facebook
twitter Twitter
facebook LinkedIn
facebook Email
facebook Print
AHA Logo
This link is provided for convenience only and is not an endorsement of either the linked-to entity or any product or service.
CLOSE PROCEED